Rather than allowing peptide use to remain confined to nonmedical distribution channels, orthopedics should lead the development of standardized perioperative registries and prospective trials using verified formulations, with the goal of determining whether peptide-based therapies can be safely integrated into evidence-based surgical optimization
[5] [10] In 2023, it was the 104th most commonly prescribed medication in the United States, with more than 6 million prescriptions
How to interpret the labs Autoimmune disease, infection risk, immune medications, and copper exposure from supplements should be reviewed clinically
It should be noted that the musculoskeletal evidence base remains preclinical, a 2025 scoping review by McGuire and colleagues in Current Reviews in Musculoskeletal Medicine found no adequately powered randomised controlled trials
Medical supervision ensures proper dosing and monitoring throughout the treatment process [11]
Here is a summary of select findings in relation to glutathione research to date